This randomized, double-blind, placebo-controlled trial evaluated the efficacy of high-dose oral vitamin C (10 g/day) in 150 patients with advanced cancer. The study found no significant differences between the vitamin C and placebo groups in terms of symptom improvement, performance status, appetite, weight, or survival duration. The median survival for
